Related Experiment Videos
The SUNCT syndrome: successfully treated with lamotrigine
Khizar Malik1, Syed Rizvi, Philippe D Vaillancourt
1State University of New York University Hospital and Medical Center, Department of Neurology, Health Science Center T21-020, Stony Brook, New York 11794-8121, USA. khizar56@yahoo.com
Pain Medicine (Malden, Mass.)
|April 23, 2004
Summary
Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) syndrome is rare and difficult to treat. Lamotrigine, an anticonvulsant, showed success in a patient resistant to other common headache medications.
Area of Science:
- Neurology
- Neuroscience
- Headache Medicine
Background:
- Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is a rare primary headache disorder.
- SUNCT syndrome is characterized by severe, unilateral, short-lasting headaches accompanied by autonomic symptoms.
- This condition is often refractory to standard treatments for primary headache disorders.
Purpose of the Study:
- To report a case of successful treatment of SUNCT syndrome.
- To evaluate the efficacy of lamotrigine in a patient with refractory SUNCT syndrome.
- To compare the effectiveness of lamotrigine against other commonly used anticonvulsants for headache treatment.
Main Methods:
- A single-patient case report.
- Administration of lamotrigine to a patient diagnosed with SUNCT syndrome.
- Assessment of treatment response and comparison with previous failed therapies, including other anticonvulsants.
Main Results:
- The patient experienced significant symptom relief with lamotrigine.
- Lamotrigine proved effective where other anticonvulsants commonly used for migraine and other headaches failed.
- This suggests a potential specific efficacy of lamotrigine in SUNCT syndrome.
Conclusions:
- Lamotrigine can be an effective treatment option for SUNCT syndrome.
- This finding offers a new therapeutic avenue for patients with this rare and debilitating headache disorder.
- Further research is warranted to confirm lamotrigine's efficacy in SUNCT syndrome.